2025. Research on the Motivation and Countermeasures of Financial Fraud of Listed Companies—Taking Kangmei Pharmaceutical as an Example. Financial Strategy and Management Reviews. 1, 2 (Aug. 2025), 1–10. DOI:https://doi.org/10.71204/y2gzjp13.